181 related articles for article (PubMed ID: 36232751)
1. Exploring Amodiaquine's Repurposing Potential in Breast Cancer Treatment-Assessment of In-Vitro Efficacy & Mechanism of Action.
Parvathaneni V; Chilamakuri R; Kulkarni NS; Baig NF; Agarwal S; Gupta V
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232751
[TBL] [Abstract][Full Text] [Related]
2. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC).
Parvathaneni V; Kulkarni NS; Chauhan G; Shukla SK; Elbatanony R; Patel B; Kunda NK; Muth A; Gupta V
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111139. PubMed ID: 32600728
[TBL] [Abstract][Full Text] [Related]
3. Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.
Parvathaneni V; Chilamakuri R; Kulkarni NS; Wang X; Agarwal S; Gupta V
Life Sci; 2022 Oct; 306():120843. PubMed ID: 35908620
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles - Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment.
Parvathaneni V; Shukla SK; Kulkarni NS; Gupta V
Int J Pharm; 2021 Oct; 608():121038. PubMed ID: 34438008
[TBL] [Abstract][Full Text] [Related]
5. The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death.
Qiao S; Tao S; Rojo de la Vega M; Park SL; Vonderfecht AA; Jacobs SL; Zhang DD; Wondrak GT
Autophagy; 2013 Dec; 9(12):2087-102. PubMed ID: 24113242
[TBL] [Abstract][Full Text] [Related]
6. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.
Kulkarni NS; Vaidya B; Parvathaneni V; Bhanja D; Gupta V
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878257
[TBL] [Abstract][Full Text] [Related]
8. Prosopis juliflora (Sw.) DC phytochemicals induce apoptosis and inhibit cell proliferation signaling pathways, EMT, migration, invasion, angiogenesis and stem cell markers in melanoma cell lines.
Choudhari J; Nimma R; Nimal SK; Totakura Venkata SK; Kundu GC; Gacche RN
J Ethnopharmacol; 2023 Aug; 312():116472. PubMed ID: 37062530
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Stearoyl-CoA Desaturase 1 Potentiates Anti-tumor Activity of Amodiaquine in Non-small Cell Lung Cancer.
Hu X; Xiang J; Li Y; Xia Y; Xu S; Gao X; Qiao S
Biol Pharm Bull; 2022 Apr; 45(4):438-445. PubMed ID: 35110426
[TBL] [Abstract][Full Text] [Related]
10. From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns.
Salentin S; Adasme MF; Heinrich JC; Haupt VJ; Daminelli S; Zhang Y; Schroeder M
Sci Rep; 2017 Sep; 7(1):11401. PubMed ID: 28900272
[TBL] [Abstract][Full Text] [Related]
11. The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity.
Espinoza JA; Zisi A; Kanellis DC; Carreras-Puigvert J; Henriksson M; Hühn D; Watanabe K; Helleday T; Lindström MS; Bartek J
Cell Death Differ; 2020 Feb; 27(2):773-789. PubMed ID: 31285544
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
Parvathaneni V; Goyal M; Kulkarni NS; Shukla SK; Gupta V
Pharm Res; 2020 Jun; 37(7):123. PubMed ID: 32514688
[TBL] [Abstract][Full Text] [Related]
13. Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control.
Antinarelli LMR; Midlej V; da Silva EDS; Coelho EAF; da Silva AD; Coimbra ES
Chem Biol Interact; 2023 Feb; 371():110333. PubMed ID: 36592711
[TBL] [Abstract][Full Text] [Related]
14. A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.
Sidarovich V; De Mariano M; Aveic S; Pancher M; Adami V; Gatto P; Pizzini S; Pasini L; Croce M; Parodi F; Cimmino F; Avitabile M; Emionite L; Cilli M; Ferrini S; Pagano A; Capasso M; Quattrone A; Tonini GP; Longo L
Mol Cancer Ther; 2018 Jul; 17(7):1405-1415. PubMed ID: 29695637
[TBL] [Abstract][Full Text] [Related]
15. Novel anti-adipogenic activity of anti-malarial amodiaquine through suppression of PPARγ activity.
Kim TH; Kim HK; Hwang ES
Arch Pharm Res; 2017 Nov; 40(11):1336-1343. PubMed ID: 29071567
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome analysis of genes associated with breast cancer cell motility in response to Artemisinin treatment.
Kumari K; Keshari S; Sengupta D; Sabat SC; Mishra SK
BMC Cancer; 2017 Dec; 17(1):858. PubMed ID: 29246124
[TBL] [Abstract][Full Text] [Related]
17. Chloroxylon swietenia (Roxb.) DC induces cell death and apoptosis by down-regulating the NF-κB pathway in MCF-7 breast cancer cells: In vitro and in vivo investigations.
Kamble SS; Choudhari J; Nimma R; Kumar TVS; Patil KK; Hese SV; Dawane BS; Gacche RN
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1600. PubMed ID: 35274824
[TBL] [Abstract][Full Text] [Related]
18. Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells.
Subramaniam V; Ace O; Prud'homme GJ; Jothy S
Exp Mol Pathol; 2011 Feb; 90(1):116-22. PubMed ID: 21040720
[TBL] [Abstract][Full Text] [Related]
19. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells.
Zhao Y; Onda K; Sugiyama K; Yuan B; Tanaka S; Takagi N; Hirano T
Oncol Rep; 2019 Jan; 41(1):27-42. PubMed ID: 30320388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
